The ARIES HeartMate 3 Pump IDE Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 628 participants.
Also called NCT04069156
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose supportive care
- Phase
- Not applicable
- Enrolled
- 628 participants
- Sponsor
- Registry
-
NCT04069156
-
- Other papers using this trial's data
- Concomitant Surgical Procedures and Aspirin Avoidance With Left Ventricular Assist Device Therapy
- Hemocompatibility Outcomes With Pharmacological Therapy Following LVAD Implantation: Insights From the ARIES-HM3 Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Australia, Austria, Canada, Czechia, France, Italy, Kazakhstan, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT04069156. Randomized; quadruple masking; primary purpose supportive care. Start 2020-07-14 (actual); primary completion 2023-08-10 (actual). Results posted on 2025-03-27.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The ARIES HeartMate 3 Pump IDE Study
- Condition
- Heart Failure
- Intervention (Device)
- LVAD Implant
- Intervention (Drug)
- Aspirin 100mg
- Intervention (Drug)
- Placebo oral tablet
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct04069156- Content hash
a56e6a55fa2f2dd9fe3edc5d6f19614b509095b3f630b1248b046198b8c6b834